World News: 13:19 GMT Friday 10th August 2018. [ORPHAZYME A/S via Globe Newswire via SPi World News]
Thomas Blaettler Chief Medical Officer said Michael Benatar, MD PhD University of Miami Principal Investigator of a prior Phase II trial of arimoclomol in SOD1 ALS and Lead International Coordinating Investigator said Lucie Bruijn , PhD, ...
Globe Newswire: 13:19 GMT Friday 10th August 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.